homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

April 25, 2017

Juno Therapeutics

Juno Therapeutics, which is developing cellular immunotherapies to treat cancer, named Sunil Agarwal, M.D. as president of research and development. He was chief medical officer at Ultragenyx.




Email or user name:
Password:
 
Forgot password? Click here.